BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 31410543)

  • 1. Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction.
    Tsai SY; Wu YW; Wang SY; Shiau YC; Chiu KM; Tsai HY; Lee CL; Hsu JC; Tu CM; Lin HH; Huang SH
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2601-2609. PubMed ID: 31410543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure.
    Mielniczuk LM; Birnie D; Ziadi MC; deKemp RA; DaSilva JN; Burwash I; Tang AT; Davies RA; Haddad H; Guo A; Aung M; Williams K; Ukkonen H; Beanlands RS
    Circ Cardiovasc Imaging; 2011 Jan; 4(1):59-66. PubMed ID: 21057116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular global longitudinal strain provides prognostic value incremental to left ventricular ejection fraction in patients with heart failure.
    Motoki H; Borowski AG; Shrestha K; Hu B; Kusunose K; Troughton RW; Tang WH; Klein AL
    J Am Soc Echocardiogr; 2014 Jul; 27(7):726-32. PubMed ID: 24679740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gated F-18 FDG PET for assessment of left ventricular volumes and ejection fraction using QGS and 4D-MSPECT in patients with heart failure: a comparison with cardiac MRI.
    Li Y; Wang L; Zhao SH; He ZX; Wang DY; Guo F; Fang W; Yang MF
    PLoS One; 2014; 9(1):e80227. PubMed ID: 24404123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle.
    van den Brom CE; Bosmans JW; Vlasblom R; Handoko LM; Huisman MC; Lubberink M; Molthoff CF; Lammertsma AA; Ouwens MD; Diamant M; Boer C
    Cardiovasc Diabetol; 2010 Jun; 9():25. PubMed ID: 20550678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of right ventricular volume and ejection fraction by gated (18)F-FDG PET in patients with pulmonary hypertension: comparison with cardiac MRI and CT.
    Wang L; Zhang Y; Yan C; He J; Xiong C; Zhao S; Fang W
    J Nucl Cardiol; 2013 Apr; 20(2):242-52. PubMed ID: 23354658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response.
    Ohira H; deKemp R; Pena E; Davies RA; Stewart DJ; Chandy G; Contreras-Dominguez V; Dennie C; Mc Ardle B; Mc Klein R; Renaud JM; DaSilva JN; Pugliese C; Dunne R; Beanlands R; Mielniczuk LM
    Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(12):1424-1431. PubMed ID: 26060207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension.
    Can MM; Kaymaz C; Tanboga IH; Tokgoz HC; Canpolat N; Turkyilmaz E; Sonmez K; Ozdemir N
    Clin Nucl Med; 2011 Sep; 36(9):743-8. PubMed ID: 21825840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.
    Motoki H; Borowski AG; Shrestha K; Troughton RW; Tang WH; Thomas JD; Klein AL
    J Am Coll Cardiol; 2012 Nov; 60(20):2074-81. PubMed ID: 23083779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characterization and prognostic significance of right ventricular glucose metabolism in non-ischemic dilated cardiomyopathy.
    Wang L; Ma X; Xiang L; Lu M; Yan C; Zhao S; Fang W
    J Nucl Cardiol; 2016 Aug; 23(4):758-67. PubMed ID: 26253326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.
    Raja S; Mittal BR; Santhosh S; Bhattacharya A; Rohit MK
    Nucl Med Commun; 2014 Nov; 35(11):1156-61. PubMed ID: 25144559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ratio of (18)F-FDG activity uptake between the right and left ventricle in patients with pulmonary hypertension correlates with the right ventricular function.
    Yang T; Wang L; Xiong CM; He JG; Zhang Y; Gu Q; Zhao ZH; Ni XH; Fang W; Liu ZH
    Clin Nucl Med; 2014 May; 39(5):426-30. PubMed ID: 24662662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy.
    Ko KY; Wang SY; Yen RF; Shiau YC; Hsu JC; Tsai HY; Lee CL; Chiu KM; Wu YW
    J Nucl Cardiol; 2020 Feb; 27(1):269-279. PubMed ID: 30109593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gated cardiac 13N-NH3 PET for assessment of left ventricular volumes, mass, and ejection fraction: comparison with electrocardiography-gated 18F-FDG PET.
    Khorsand A; Graf S; Eidherr H; Wadsak W; Kletter K; Sochor H; Schuster E; Porenta G
    J Nucl Med; 2005 Dec; 46(12):2009-13. PubMed ID: 16330564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of left and right ventricular functional parameters using dynamic dual-tracer [
    Rasul S; Beitzke D; Wollenweber T; Rausch I; Lassen ML; Stelzmüller ME; Mitterhauser M; Pichler V; Beyer T; Loewe C; Hacker M
    J Nucl Cardiol; 2022 Jun; 29(3):1003-1017. PubMed ID: 33094471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between mechanical and metabolic dyssynchrony with left bundle branch block: evaluation by 18-fluorodeoxyglucose positron emission tomography in patients with non-ischemic heart failure.
    Castro P; Winter JL; Verdejo H; Orellana P; Quintana JC; Greig D; Enríquez A; Sepúlveda L; Concepción R; Sepúlveda P; Rossel V; Chiong M; García L; Lavandero S
    J Heart Lung Transplant; 2012 Oct; 31(10):1096-101. PubMed ID: 22975099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of volumetric and functional parameters in simultaneous cardiac PET/MR: feasibility of volumetric assessment with residual activity from prior PET/CT.
    Lücke C; Oppolzer B; Werner P; Foldyna B; Lurz P; Jochimsen T; Brenneis B; Lehmkuhl L; Sattler B; Grothoff M; Barthel H; Sabri O; Gutberlet M
    Eur Radiol; 2017 Dec; 27(12):5146-5157. PubMed ID: 28631080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.
    Burke MA; Katz DH; Beussink L; Selvaraj S; Gupta DK; Fox J; Chakrabarti S; Sauer AJ; Rich JD; Freed BH; Shah SJ
    Circ Heart Fail; 2014 Mar; 7(2):288-99. PubMed ID: 24365774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of β-blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation.
    Galves R; Da Costa A; Pierrard R; Bayard G; Guichard JB; Isaaz K
    Echocardiography; 2020 Sep; 37(9):1392-1398. PubMed ID: 32815195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.